Atlas Trials

A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia

Clinical trial NCT05646264 · UNKNOWN

Trial details

NCT number
NCT05646264
Sponsor
Shanghai Mental Health Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaNegative Symptoms in Schizophrenia
Start date
2023-01-01
Primary completion
2023-08-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.